$3 million for blood cancer research

An exceptional partnership to outsmart blood cancers

Beyond the technical terminology of leukemias, myelomas, lymphomas, myelodysplastic syndromes, and myeloproliferative neoplasms, lies a far more striking reality: more than 155,000 Canadians are grappling with diverse forms of blood cancers. These cancers strike unpredictably, impacting children, young adults, and the elderly alike.

In response to this reality, the Cancer Research Society (CRS) and the Leukemia and Lymphoma Society of Canada (LLSC) are jointly announcing an exceptional partnership, amounting to $3 million, dedicated to research on blood cancers.

This collaboration enables the funding of 15 research projects, each receiving a financial support of $200,000 over a two-year period. Each of these projects has been carefully selected by esteemed scientific peers, distinguished by their promising potential, innovative character, and capacity to deepen our understanding of the underlying mechanisms driving blood cancers. Moreover, these research studies also pave the way for new perspectives on more effective and personalized patient treatments.

By joining forces in this remarkable partnership, we demonstrate our commitment to supporting cutting-edge research to outsmart blood cancers,” declares Dajan O’Donnell, PhD, Director, Scientific Affairs and Partnerships at the CRS. “The Cancer Research Society supports projects that explore the many facets of blood cancers while improving therapeutic options. By optimizing strategic partnerships, we ensure that each donation becomes an impulse for research, thus amplifying our impact.”

“We are able to invest in more of Canada’s leading blood cancer researchers conducting vital and innovative investigations through partnerships such as this, says Nadine Prevost, business unit director – Research and community support, LLSC. “We support both the research of, and people affected by, 137 types of blood cancer within leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms.

 We are pleased to reveal the recipients of these grants:

  • Dalia Barsyte-Lovejoy, University of Toronto, Toronto, Ontario
  • Tobias Berg, McMaster University, Faculty of Health Sciences, Hamilton, Ontario
  • Jonathan Bramson, McMaster University, Faculty of Health Sciences, Hamilton
  • Rodney DeKoter, The University of Western Ontario, London, Ontario
  • Sonia del Rincon, Lady Davis Institute at the Jewish General Hospital, Montreal, Quebec
  • Brett Houston, University of Manitoba, Winnipeg, Manitoba
  • Valentin Jaumouillé, Simon Fraser University, Burnaby, British Columbia
  • Robert Kridel, University Health Network, Toronto, Ontario
  • Anastasia Nijnik, The Royal Institution for the Advancement of Learning, McGill University, Montreal, Quebec
  • Claude Perreault, University of Montreal, Montreal, Quebec
  • Paul Spagnuolo, University of Guelph, Guelph, Ontario
  • David Spaner, Sunnybrook Research Institute, Toronto, Ontario
  • Ly Vu, University of British Columbia, Vancouver, British Columbia
  • Jean Wang, University Health Network, Toronto, Ontario
  • Yuliang Wu, University of Saskatchewan, Saskatoon, Saskatchewan

The alliance between CRS and LLSC reveals a deep commitment to research and innovation to combat these types of blood cancer. This partnership and the researchers’ hard work convey a message of perseverance and hope to all those affected by these cancers.

We are pleased to inform you that CRS and LLSC have decided to renew their partnership next year to continue the efforts to overcome blood cancers.

About Cancer Research Society:

Since 1945, the Cancer Research Society (CRS) is one of the only Canadian organizations exclusively dedicated to research into all types of cancer. To date, the CRS has distributed over $355 million in research grants and scholarships and supported thousands of researchers who have made significant advances to prevent, detect and treat cancer thanks to the generosity of partners and donors throughout Canada.  To learn more, visit our website CancerResearchSociety.ca. You can follow our news on: Twitter/X @SRC_CRS, and Instagram | Facebook LinkedIn.

About the Leukemia and Lymphoma Society of Canada:

The Leukemia and Lymphoma Society of Canada (LLSC) is the only nonprofit organization in Canada that provides services, support, and educational resources to people affected by all types of blood cancer, as well as funding research into all types of blood cancers. More information at bloodcancers.ca @LLSCanada on Twitter/X and Instagram | Facebook | LinkedIn


The Cancer Research Society is a Member of Research Canada: An Alliance for Health Discovery. Visit rc-rc.ca to learn more.